[Prospects for the use of prostaglandins in pediatric cardiology].
D016861:Cyclooxygenase Inhibitors; D004373:Ductus Arteriosus / Q000187:drug effects; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000627:therapeutic use*; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D011459:Prostaglandins E, Synthetic; D011465:Prostaglandins, Synthetic; D011464:Epoprostenol; D007213:Indomethacin
Perspektywy stosowania prostaglandyn w kardiologii u dzieci.